Vinay K. Malviya

Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer

David S. Alberts, P. Y. Liu, Edward V. Hannigan et al. · New England Journal of Medicine · 1996 · 1.2K citations · Full text

Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer: A southwest oncology group study

David S. Alberts, Steve Dahlberg, Stephanie Green et al. · Cancer · 2010 · 74 citations

Reliability of frozen section examination in identifying poor prognostic indicators in Stage I endometrial adenocarcinoma

Vinay K. Malviya, Gunter Deppe, John M. Malone et al. · Gynecologic Oncology · 1989 · 68 citations

Intraoperative Consultation, Cancer Detection, Medicine +8

Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone

Dwight E. Saunders, Carl Christensen, N.L. Wappler et al. · Anti-Cancer Drugs · 1993 · 68 citations

Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells.

Y L Cho, Carl Christensen, Dwight E. Saunders et al. · PubMed · 1991 · 60 citations

Chemoprevention Strategy, Cell Proliferation, Pharmacotherapy +17